January 9, 2013

Forbes: "What Firepower? Why Big Drugmakers Can't Do Big Deals"

Courtesy of a friend of the blog (Thank you). The author is Ed Silverman. His full article is here.

"Bolt-on" = $2-4 billion. "A bolt-on is an acquisition that, essentially, fits neatly into an existing line up." Recall my post $PVCT: Immunologic Potential, and thus Value.

No comments:

Post a Comment